CLINICAL PHARMACOLOGICAL APPROACH TO THE RATIONAL USE OF DRUGS IN ARRHYTHMIA SYNDROME
Main Article Content
Abstract
Ventricular arrhythmias (VA) of the heart are among the most common and complex arrhythmias. They occur in acute and chronic diseases, and sometimes in practically healthy individuals. Holter ECG monitoring (HM ECG) reveals ventricular extrasystole (VE) in approximately 50–80% of individuals without signs of cardiovascular disease, and high grade VC is detected in 25–35% of cases. And in patients with coronary heart disease (CHD), this type of arrhythmia is recorded in more than 90% of cases. PVCs are more common in older people.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Ardashev V.N., Steklov V.I. Treatment of heart rhythm disorders, M: Med-praktika, 2010, 169 p.
Bokalov S.A., Golitsyn S.P., Malakhov V.I. and others. Antiarrhythmic treatment of patients with recurrent ventricular tachycardia after myocardial infarction. Cardiology 2012; 2:55–58.
Bockeria L.A., Golukhova E.Z., Adamyan M.G., Bockeria O.L. and others. Clinical and functional features of ventricular arrhythmias in patients with coronary heart disease. Cardiology 2018; 10:17–24.
Bockeria L.A., Fedorov G.G. Surgical treatment of patients with post-infarction cardiac aneurysms and concomitant tachyarrhythmias. Thoracic Surgery 2014; 6:4–8.
Golitsyn S.P., Savelyeva I.V., Bakalov S.A. Treatment of patients with ventricular cardiac arrhythmias: possibilities and limitations. Cardiology 2018: 10:67–77.